Stockscreener 앱 받기
0.127
5.93%
-0.008
시간 외 거래:
.13
0.003
+2.36%
전일 마감가:
$0.135
열려 있는:
$0.132
하루 거래량:
7.80M
Relative Volume:
1.75
시가총액:
$128.77M
수익:
$25.19M
순이익/손실:
$-34.53M
주가수익비율:
-5.5217
EPS:
-0.023
순현금흐름:
$-20.62M
1주 성능:
+3.76%
1개월 성능:
+3.00%
6개월 성능:
-26.89%
1년 성능:
-24.00%
1일 변동 폭
$0.1257
$0.1334
1주일 범위
$0.1211
$0.1548
52주 변동 폭
$0.117
$0.2285
조메디카 Stock (ZOM) Company Profile
명칭
Zomedica Corp
전화
734-369-2555
주소
100 Phoenix Drive, Suite 190, Ann Arbor, MI
ZOM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| ZOM | 0.127 | 128.77M | 25.19M | -34.53M | -20.62M | -0.023 |
| ZTS | 176.42 | 79.51B | 9.15B | 2.43B | 2.31B | 4.92 |
| TAK | 13.53 | 42.89B | 30.27B | 1.93B | 3.45B | 0.444 |
| HLN | 9.43 | 42.57B | 14.26B | 1.55B | 0 | 0.3327 |
| TEVA | 16.49 | 18.51B | 16.77B | -959.00M | 1.37B | -2.00 |
| VTRS | 13.00 | 15.37B | 15.24B | -646.50M | 1.88B | 1.53 |
조메디카 Stock (ZOM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-01-06 | 개시 | Dawson James | Buy |
조메디카 주식(ZOM)의 최신 뉴스
Noble Financial Predicts Zomedica FY2024 Earnings - MarketBeat
Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform - AccessWire
Zomedica Launches 18-Minute Equine Insulin Test, Expands TRUFORMA Platform Capabilities | ZOM Stock News - StockTitan
Johnny D. Powers Purchases 100,000 Shares of Zomedica Corp. (NYSEAMERICAN:ZOM) Stock - MarketBeat
Zomedica (NYSEAMERICAN:ZOM) Stock Rating Upgraded by Noble Financial - MarketBeat
Noble Capital Markets Initiates Equity Research Coverage on Zomedica - AccessWire
Zomedica (ZOM) Launches Noble Capital Markets Coverage to Boost Market Visibility | ZOM Stock News - StockTitan
Zomedica initiated with an Outperform at Noble Capital - TipRanks
Zomedica Corp. (AMEX:ZOM) Q3 2024 Earnings Call Transcript - Insider Monkey
Zomedica Corp (ZOM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... By GuruFocus - Investing.com Canada
Earnings call: Zomedica reports record Q3 revenue, eyes future growth By Investing.com - Investing.com Australia
Zomedica stock plunges to 52-week low of $0.12 amid market challenges By Investing.com - Investing.com South Africa
Earnings call: Zomedica reports record Q3 revenue, eyes future growth - Investing.com
Zomedica’s Revenue Up 10% Amid Global Expansion - TipRanks
Zomedica stock plunges to 52-week low of $0.12 amid market challenges - Investing.com India
Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024 - Herald Palladium
Zomedica CEO to Present at Sidoti Micro Cap Conference, Showcases Pet Health Innovation | ZOM Stock News - StockTitan
Zomedica Corp Posts Increased Revenue Amid Loss - TipRanks
Zomedica Announces Third Quarter 2024 Financial Results: Revenue - WICZ
Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth - AccessWire
Zomedica Q3 Revenue Jumps 10%, Diagnostics Surges 38% Despite Wider Losses | ZOM Stock News - StockTitan
Zomedica stock plunges to 52-week low at $0.12 amid market challenges - Investing.com India
ZOMZomedica Corp. Latest Stock News & Market Updates - StockTitan
Zomedica Launches Ear Cytology Quick Scan Protocol for TRUVIEW(TM) Digital Microscope & Telepathology Platform - AccessWire
Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ET - AccessWire
Zomedica stock plunges to 52-week low at $0.12 amid market challenges By Investing.com - Investing.com South Africa
Adversity is less terrifying than hope: Zomedica Corp (ZOM) - SETE News
Stock Market Recap: Zomedica Corp (ZOM) Concludes at 0.13, a -2.01 Surge/Decline - The Dwinnex
Zomedica Announces Sponsorship of Educational Presentations at the Fetch Coastal Conference - Lelezard
Zomedica Corp’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle
Zomedica Corp [ZOM] stock Initiated by Dawson James analyst, price target now $6 - The DBT News
Daily Market Movement: Zomedica Corp (ZOM) Sees a -0.46 Decrease, Closing at 0.13 - The Dwinnex
CEO HEATON LARRY C II acquired 100,000 shares of Zomedica Corp [ZOM] - Knox Daily
What technical indicators reveal about ZOM stock - US Post News
Zomedica Corp Inc. (ZOM) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle
There is no way Zomedica Corp (ZOM) can keep these numbers up - SETE News
Understanding the Risks of Investing in Zomedica Corp (ZOM) - Knox Daily
Zomedica expands distribution agreement in Europe with Grovet - MSN
ZOM’s valuation metrics: A comprehensive analysis - US Post News
Zomedica Strengthens European Foothold With Grovet Partnership, Expanding PulseVet And TRUFORMA Reach - Benzinga
Zomedica Corp (ZOM) Stock: A Year of Decreases and Increases - The InvestChronicle
Zomedica Announces Expansion of Exclusive Equine Distribution Agreement with Grovet in Europe - Herald Palladium
Its Stock Has Paid Off Big Time For Zomedica Corp - SETE News
Market cap of Zomedica Corp [ZOM] reaches 127.59M – now what? - The DBT News
Zomedica Corp (ZOM) Stock: A Year of Market Fluctuations - The InvestChronicle
조메디카 (ZOM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.79%
0.15%
자본화:
|
볼륨(24시간):